Supplementary Text: Genetic Epidemiology of Parkinson S Disease (GEO-PD) Consortium

Supplementary Text: Genetic Epidemiology of Parkinson’s Disease (GEO-PD) Consortium

Demetrius M. Maraganore, MD (NorthShore University HealthSystem, Chicago, IL; executive medical director, clinical core director, global site principal investigator)

Matthew J. Farrer PhD (University of British Columbia, Vancouver, BC, Canada; executive scientific director, genotyping core director, global site principal investigator)

Jan O. Aasly MD (University of Trondheim, Trondheim, Norway; clinical core director, global site principal investigator)

RejkoKrüger MD PhD (University of Tübingen, Tübingen, Germany; genotyping core director, global site principal investigator)

Alexis Elbaz MD PhD (Institut national de la santé et de la recherche médicale and University Paris-Sud 11; statisticalcoredirector, global site principal investigator)

John P. Ioannidis MD PhD (Stanford University, Palo Alto, CA, USA; statistical core director)

Grazie Annesi, PhD (Institute of Molecular Bioimaging and Physiology, National Research Council, University of Magna Graecia, Catanzaro, Italy; global site principal investigator)

Enza Maria Valente, MD PhD (IRCCS Casa SollievodellaSofferenza Hospital, Mendel Laboratory, San Giovanni Rotondo, Italy; global site principal investigator)

Maria Bozi, MD (General Hospital of Syros, Syros, Greece; global site principal investigator)

Alexis Brice, MD (Universite Pierre et Marie Curie, Paris, France; global site principal investigator)

Andrea Carmine-Belin, PhD (KarolinskaInstitutet, Stockholm, Sweden; global site principal investigator)

Jonathan Carr, MD (University of Stellenbosch, Cape Town, South Africa; global site principal investigator)

Camille Carroll, MD PhD (Plymouth University Peninsula Schools of Medicine and Dentistry, England; global site principal investigator)

Sheng-Di Chen, MD (Ruijin Hospital and Shanghai Jiao Tong University School of Medicine, Shanghai, China; global site principal investigator)

Sun Ju Chung, MD PhD (Asan Medical Center, Seoul, Korea; global site principal investigator)

Carlos Cosentino, MD (Instituto de CienciasNeurologicas, Lima, Peru; global site principal investigator)

SilkeCresswell, MD (University of British Columbia, Canada; global site principal investigator)

Angela Deutschlaender, MD (Max-Planck Institute of Psychiatry, Munich, Germany; global site principal investigator)

Carlo Ferrarese, MD PhD (University of Milano-Bicocca, Monza, Italy; global site principal investigator)

Tatiana Foroud, PhD (Indiana University, Indianapolis, IN, USA; global site principal investigator)

GaëtanGarraux, MD PhD (University Hospital of Liege, Belgium; global site principal investigator)

Stefano Goldwurm, MD PhD (Parkinson Institute, Milan, Italy; global site principal investigator)

George Hadjigeorgiou, MD PhD (University of Thessaly, Larissa, Greece; global site principal investigator)

Marie-Christine Chartier-Harlin, PhD (University Lille Nord de France, France; global site principal investigator)

Anhar Hassan, MB BCh (Mayo Clinic Rochester, MN, USA; global site principal investigator)

Nobutaka Hattori, MD PhD (Juntendo University, Tokyo, Japan; global site principal investigator)

FaycalHentati, MD (Mongi Ben HamidaNatonal Institute of Neurology, La Rabta, Tunisia; global site principal investigator)

BeomSeokJeon, MD PhD (Seoul National Hospital, Seoul, Korea; global site principal investigator)

Hideshi Kawakami, MD PhD (University of Hiroshima, Hiroshima, Japan; global site principal investigator)

Yun Joong Kim, MD PhD (Hallym University, Anyang, Kyonggi-do, Korea; global site principal investigator)

Asha Kishore MD DM (SreeChitraTirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India; global site principal investigator)

Christine Klein, MD PhD (University of Luebeck, Luebeck, Germany; global site principal investigator)

SulevKoks, MD PhD (University of Tartu, Estonia; global site principal investigator)

Dimitri Krainc, MD PhD (Massachusetts General Hospital, Harvard Medical School, Boston, USA; global site principal investigator)

RejkoKrüger, MD PhD (University of Tübingen, Tübingen, Germany; global site principal investigator)

Anna Krygowska-Wajs, MD PhD (Collegium Medicum, Jagiellonian University, Krakow, Poland; global site principal investigator)

Juei-Jueng Lin, MD (Chushagn Show-Chwan Hospital, Nantou, Taiwan; global site principal investigator)

Tim Lynch, MB, BSc, DCH, FRCPI, FRCP, ABPN (The Dublin Neurological Institute, Dublin, Ireland; global site principal investigator)

Demetrius M. Maraganore, MD (NorthShore University HealthSystem, Evanston, IL, USA; global site principal investigator)

George Mellick, PhD (Griffith University, Nathan, Queensland, Australia; global site principal investigator)

Karen E. Morrison, DPhil, FRCP (University of Birmingham, UK; global site principal investigator)

Renato P. Munhoz, MD (Paraná Parkinson’s Disease Foundation, Curitiba/PR, Brazil; global site principal investigator)

Grzegorz Opala, MD PhD (Medical University of Silesia, Katowice, Poland; global site principal investigator)

Pao Pastor MD PhD (University of Navarra School of Medicine, Pamplona, Spain; global site principal investigator)

HaydehPayami, PhD (Wadsworth Center, Albany, New York; global site principal investigator)

Sofya N. Pchelina, PhD (Pavlov State Medical University of Saint Petersburg, Saint Petersburg, Russia; global site principal investigator)

Maria Skaalum Petersen, PhD (The Faroese Hospital System, Faroe Islands; global site principal investigator)

Andrea Puschmann, MD PhD (Skane University Hospital, Lund, Sweden; global site principal investigator)

Beate Ritz, MD PhD (University of California, Los Angeles, CA, USA; Parkinson’s Disease in Denmark, PASIDA; global site principal investigator)

Ekaterina Rogaeva, PhD (University of Toronto, Canada; global site principal investigator)

Ali Sazci, PhD (University of Kocaeli, Kocaeli, Turkey; global site principal investigator)

JaroslawSlawek, MD PhD (Medical University of Gdansk, Poland; global site principal investigator)

Leonidas Stefanis, MD PhD (University of Athens Medical School, Athens, Greece; global site principal investigator)

Eng-King Tan, MD FRCP (Singapore General Hospital, National Neuroscience Institute, Singapore; global site principal investigator)

Tatsushi Toda, MD PhD (Osaka University Graduate School of Medicine, Osaka, Japan; global site principal investigator)

Matthias Toft, MD PhD (Oslo University Hosptial, Oslo, Norway; global site principal investigator)

Christine Van Broeckhoven, PhD DSc (VIB, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium; global site principal investigator)

Karin Wirdefeldt, MD PhD (Karolinska Institute, Stockholm, Sweden; global site principal investigator)

Dirk Woitalla, MD (St. Josef Hospital Bochum, Dept. of Neurology, Ruhr Univ. Bochum, Germany; global site principal investigator)

Zbigniew K. Wszolek, MD (Mayo Clinic, Jacksonville, FL, USA; global site principal investigator)

Alexander Zimprich, MD (Medical University, Vienna, Austria; global site principal investigator)